SCHEMBL2623760

SCHEMBL2623760

CCC(C)c1ccc(Nc2ccc(N(C3=NC4=NC(N(c5ccccc5)c5ccccc5)=NC5=NC(N(c6ccccc6)c6ccccc6)=NC(=N3)N54)c3ccccc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP26A1 O43174 2/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 2/20 0.37
TP53 P04637 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 2/20 0.34
CDK4 P11802 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2623759 0.92 MEN1 (0.34) ALDH1A1RAB9ANPC1SMN1; SMN2CYP2C9
SCHEMBL2623758 0.89 CYP17A1 (0.36) KMT2AMEN1
SCHEMBL2623754 0.86 GRM2 (0.32) ALDH1A1RAB9ANPC1CYP2C9KMT2A
SCHEMBL2623761 0.85 KDM4C (0.39) ALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL1900066 0.75 ALDH1A1 (0.53) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD
SCHEMBL2623728 0.75 L3MBTL1 (0.37) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL19413370 0.73 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL14523554 0.73 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2300944 0.73 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL12012665 0.73 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120091884-A1 HEPTAAZAPHENALENE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AT) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120091884-A1 HEPTAAZAPHENALENE DERIVATIVES AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE HSD17B2, CYP1A2, HSD17B1 ALDH1A1 15/4885RAB9A 2062/4885NPC1 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.